Report cover image

MASH Treatment Global Market Opportunities And Strategies To 2034

Publisher The Business Research Company
Published Sep 18, 2025
Length 312 Pages
SKU # BRC20410890

Description

MASH Treatment Global Market Opportunities and Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global MASH treatment market as it emerges from the COVID-19 shut down.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Description:

Where is the largest and fastest-growing market for MASH treatment? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The MASH treatment market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider MASH treatment market; and compares it with other markets.

The report covers the following chapters
  • Introduction And Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by treatment, by end user and by disease stage.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Growth Analysis And Strategic Analysis Framework- Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
  • Regional And Country Analysis- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by treatment, by end user and by disease stage in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
  • Regional Market Size And Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers And Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Recent Developments- Information on recent developments in the market covered in the report.
  • Market Opportunities And Strategies:- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations:- This section includes recommendations for MASH treatment market providers in terms of product/service offerings geographic expansion, marketing strategies and target groups
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:

1) By Treatment: Drug; Therapy

2) By Disease Stage: Simple Fatty Liver / MASLD (No Or Mild Fibrosis); Early MASH (Significant/Advanced Fibrosis); Fibrotic MASH; MASH Cirrhosis And Liver Failure / Liver Cancer Mortality

3) By End-User: Hospitals; Specialty Clinics; Homecare; Other End-User

Companies Mentioned: Madrigal Pharmaceuticals Inc.; Novo Nordisk A/S; Eli Lilly Company; AstraZeneca plc; Mayo Clinic

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time-series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; MASH treatment indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

312 Pages
1 Executive Summary
1.1 MASH Treatment – Market Attractiveness And Macro Economic Landscape
2 Table Of Contents
3 List Of Tables
4 List Of Figures
5 Report Structure
6 Market Characteristics
6.1 General Market Definition
6.2 Summary
6.3 MASH Treatment Market Definition And Segmentations
6.4 Market Segmentation By Treatment
6.4.1 Drug
6.4.2 Therapy
6.5 Market Segmentation By Disease Stage
6.5.1 Simple Fatty Liver / MASLD (No Or Mild Fibrosis)
6.5.2 Early MASH (Significant/Advanced Fibrosis)
6.5.3 Fibrotic MASH
6.5.4 MASH Cirrhosis
6.5.5 Liver Failure / Liver Cancer Mortality
6.6 Market Segmentation By End-User
6.6.1 Hospitals
6.6.2 Specialty Clinics
6.6.3 Homecare
6.6.4 Other End-User
7 Major Market Trends
7.1 Advancements In Fibroblast Growth Factors (FGFs) Through Acquisitions
7.2 Integration Of Artificial Intelligence (AI) In MASH Treatment
7.3 Strategic Partnerships And Collaborations Among Market Players
7.4 Focus On Receiving Government Approvals To Highlight Advancements in MASH Treatment
7.5 Innovative MASH Treatments Address Fibrosis And Improve Liver Health Outcomes
8 MASH Treatment Growth Analysis And Strategic Analysis Framework
8.1 Global MASH Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors)
8.1.1 Political
8.1.2 Economic
8.1.3 Social
8.1.4 Technological
8.1.5 Environmental
8.1.6 Legal
8.2 Analysis Of End User Industries (B2B)
8.2.1 Hospitals
8.2.2 Specialty Clinics
8.2.3 Homecare
8.2.4 Other End-User
8.3 MASH Treatment Market Growth Rate Analysis
8.4 Historic Market Growth, 2019 – 2024, Value ($ Million)
8.4.1 Market Drivers 2019 – 2024
8.4.2 Market Restraints 2019 – 2024
8.5 Forecast Market Growth, 2024 – 2029, 2034F Value ($ Million)
8.6 Forecast Growth Contributors/Factors
8.6.1 Quantitative Growth Contributors
8.6.2 Drivers
8.6.3 Restraints
8.7 MASH Treatment Total Addressable Market (TAM)
9 MASH Treatment Market Segmentation
9.1 MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
9.2 MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
9.3 MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
9.4 MASH Treatment Market, Sub-Segmentation Of Drug, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
9.5 MASH Treatment Market, Sub-Segmentation Of Therapy, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
10 MASH Treatment Market, Regional and Country Analysis
10.1 MASH Treatment Market, By Region, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
10.2 MASH Treatment Market, By Country, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11 Asia-Pacific Market
11.1 Summary
11.2 Market Overview
11.2.1 Region Information
11.2.2 Market Information
11.2.3 Background Information
11.2.4 Government Initiatives
11.2.5 Regulations
11.2.6 Regulatory Bodies
11.2.7 Major Associations
11.2.8 Taxes Levied
11.2.9 Corporate Tax Structure
11.2.10 Investments
11.2.11 Major Companies
11.3 Asia-Pacific MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.4 Asia-Pacific MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.5 Asia-Pacific MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.6 Asia-Pacific MASH Treatment Market: Country Analysis
11.7 China Market
11.8 Summary
11.9 Market Overview
11.9.1 Country Information
11.9.2 Market Information
11.9.3 Background Information
11.9.4 Government Initiatives
11.9.5 Regulations
11.9.6 Regulatory Bodies
11.9.7 Major Associations
11.9.8 Taxes Levied
11.9.9 Corporate Tax Structure
11.9.10 Investments
11.9.11 Major Companies
11.10 China MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.11 China MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.12 China MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.13 India Market
11.14 India MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.15 India MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.16 India MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.17 Japan Market
11.18 Summary
11.19 Market Overview
11.19.1 Country Information
11.19.2 Market Information
11.19.3 Background Information
11.19.4 Government Initiatives
11.19.5 Regulations
11.19.6 Regulatory Bodies
11.19.7 Major Associations
11.19.8 Taxes Levied
11.19.9 Corporate Tax Structure
11.19.10 Investments
11.19.11 Major Companies
11.20 Japan MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.21 Japan MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.22 Japan MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.23 Australia Market
11.24 Australia MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.25 Australia MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.26 Australia MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.27 Indonesia Market
11.28 Indonesia MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.29 Indonesia MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.30 Indonesia MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.31 South Korea Market
11.32 Summary
11.33 Market Overview
11.33.1 Country Information
11.33.2 Market Information
11.33.3 Background Information
11.33.4 Government Initiatives
11.33.5 Regulations
11.33.6 Regulatory Bodies
11.33.7 Major Associations
11.33.8 Taxes Levied
11.33.9 Corporate Tax Structure
11.33.10 Investments
11.33.11 Major Companies
11.34 South Korea MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.35 South Korea MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.36 South Korea MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12 Western Europe Market
12.1 Summary
12.2 Market Overview
12.2.1 Region Information
12.2.2 Market Information
12.2.3 Background Information
12.2.4 Government Initiatives
12.2.5 Regulations
12.2.6 Regulatory Bodies
12.2.7 Major Associations
12.2.8 Taxes Levied
12.2.9 Corporate tax structure
12.2.10 Investments
12.2.11 Major Companies
12.3 Western Europe MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.4 Western Europe MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.5 Western Europe MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.6 Western Europe MASH Treatment Market: Country Analysis
12.7 UK Market
12.8 UK MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.9 UK MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.10 UK MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.11 Germany Market
12.12 Germany MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.13 Germany MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.14 Germany MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.15 France Market
12.16 France MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.17 France MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.18 France MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.19 Italy Market
12.20 Italy MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.21 Italy MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.22 Italy MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.23 Spain Market
12.24 Spain MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.25 Spain MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.26 Spain MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13 Eastern Europe Market
13.1 Summary
13.2 Market Overview
13.2.1 Region Information
13.2.2 Market Information
13.2.3 Background Information
13.2.4 Government Initiatives
13.2.5 Regulations
13.2.6 Regulatory Bodies
13.2.7 Major Associations
13.2.8 Taxes Levied
13.2.9 Corporate Tax Structure
13.2.10 Major companies
13.3 Eastern Europe MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.4 Eastern Europe MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.5 Eastern Europe MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.6 Eastern Europe MASH Treatment Market: Country Analysis
13.7 Russia Market
13.8 Russia MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.9 Russia MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.10 Russia MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14 North America Market
14.1 Summary
14.2 Market Overview
14.2.1 Region Information
14.2.2 Market Information
14.2.3 Background Information
14.2.4 Government Initiatives
14.2.5 Regulations
14.2.6 Regulatory Bodies
14.2.7 Major Associations
14.2.8 Taxes Levied
14.2.9 Corporate Tax Structure
14.2.10 Investments
14.2.11 Major Companies
14.3 North America MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.4 North America MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.5 North America MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.6 North America MASH Treatment Market: Country Analysis
14.7 USA Market
14.8 Summary
14.9 Market Overview
14.9.1 Country Information
14.9.2 Market Information
14.9.3 Background Information
14.9.4 Government Initiatives
14.9.5 Regulations
14.9.6 Regulatory Bodies
14.9.7 Major Associations
14.9.8 Taxes Levied
14.9.9 Corporate Tax Structure
14.9.10 Investments
14.9.11 Major Companies
14.10 USA MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.11 USA MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.12 USA MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.13 Canada Market
14.14 Summary
14.15 Market Overview
14.15.1 Country Information
14.15.2 Market Information
14.15.3 Background Information
14.15.4 Government Initiatives
14.15.5 Regulations
14.15.6 Regulatory Bodies
14.15.7 Major Associations
14.15.8 Taxes Levied
14.15.9 Corporate Tax Structure
14.15.10 Investments
14.15.11 Major Companies
14.16 Canada MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.17 Canada MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.18 Canada MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15 South America Market
15.1 Summary
15.2 Market Overview
15.2.1 Region Information
15.2.2 Market Information
15.2.3 Background Information
15.2.4 Government Initiatives
15.2.5 Regulations
15.2.6 Regulatory Bodies
15.2.7 Major Associations
15.2.8 Taxes Levied
15.2.9 Corporate Tax Structure
15.2.10 Major Companies
15.3 South America MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.4 South America MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.5 South America MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.6 South America MASH Treatment Market: Country Analysis
15.7 Brazil Market
15.8 Brazil MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.9 Brazil MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.10 Brazil MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
16 Middle East Market
16.1 Summary
16.2 Market Overview
16.2.1 Region Information
16.2.2 Market Information
16.2.3 Background Information
16.2.4 Government Initiatives
16.2.5 Regulations
16.2.6 Regulatory Bodies
16.2.7 Major Associations
16.2.8 Taxes Levied
16.2.9 Corporate Tax Structure
16.2.10 Major Companies
16.3 Middle East MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
16.4 Middle East MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
16.5 Middle East MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
17 Africa Market
17.1 Summary
17.2 Market Overview
17.2.1 Region Information
17.2.2 Market Information
17.2.3 Background Information
17.2.4 Government Initiatives
17.2.5 Regulations
17.2.6 Regulatory Bodies
17.2.7 Major Associations
17.2.8 Taxes Levied
17.2.9 Corporate Tax Structure
17.2.10 Major Companies
17.3 Africa MASH Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
17.4 Africa MASH Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
17.5 Africa MASH Treatment Market, Segmentation By Disease Stage, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
18 Competitive Landscape And Company Profiles
18.1 Company Profiles
18.2 Madrigal Pharmaceuticals Inc.
18.2.1 Company Overview
18.2.2 Products And Services
18.2.3 Business Strategy
18.2.4 Financial Overview
18.3 Novo Nordisk A/S
18.3.1 Company Overview
18.3.2 Products And Services
18.3.3 Financial Overview
18.4 Eli Lilly Company
18.4.1 Company Overview
18.4.2 Products And Services
18.4.3 Business Strategy
18.4.4 Financial Overview
18.5 AstraZeneca plc
18.5.1 Company Overview
18.5.2 Products And Services
18.5.3 Business Strategy
18.5.4 Financial Overview
18.6 Mayo Clinic
18.6.1 Company Overview
18.6.2 Products And Services
18.6.3 Financial Overview
19 Other Major And Innovative Companies
19.1 Zydus Lifesciences
19.1.1 Company Overview
19.1.2 Products And Services
19.2 King’s College Hospital
19.2.1 Company Overview
19.2.2 Products And Services
19.3 Johns Hopkins Hospital
19.3.1 Company Overview
19.3.2 Products And Services
19.4 Imperial College Healthcare NHS Trust
19.4.1 Company Overview
19.4.2 Products And Services
19.5 Cleveland Clinic
19.5.1 Company Overview
19.5.2 Products And Services
19.6 HighTide Therapeutics Inc.
19.6.1 Company Overview
19.6.2 Products And Services
19.7 Sagimet Biosciences
19.7.1 Company Overview
19.7.2 Products And Services
19.8 Rivus Pharmaceuticals
19.8.1 Company Overview
19.8.2 Products And Services
19.9 89bio Inc.
19.9.1 Company Overview
19.9.2 Products And Services
19.10 Dr. Falk Pharma
19.10.1 Company Overview
19.10.2 Products And Services
19.11 Akero Therapeutics
19.11.1 Company Overview
19.11.2 Products And Services
19.12 NorthSea Therapeutics BV
19.12.1 Company Overview
19.12.2 Products And Services
19.13 Lipocine Inc.
19.13.1 Company Overview
19.13.2 Products And Services
19.14 Cirius Therapeutics
19.14.1 Company Overview
19.14.2 Products And Services
19.15 Alimentiv Inc.
19.15.1 Company Overview
19.15.2 Products And Services
20 Competitive Benchmarking
21 Competitive Dashboard
22 Key Mergers And Acquisitions
22.1 GlaxoSmithKline (GSK) Acquired efimosfermin From Boston Pharmaceuticals
22.2 Gilead Sciences Acquired CymaBay Therapeutics
23 Recent Developments In MASH Treatment
23.1 Home-Based Therapeutic Approach Gains Traction In MASH Management
23.2 Next-Gen FGF21 Therapy Under Investigation For MASH Management
24 Opportunities And Strategies
24.1 MASH Treatment Market In 2029 – Countries Offering Most New Opportunities
24.2 MASH Treatment Market In 2029 – Segments Offering Most New Opportunities
24.3 MASH Treatment Market In 2029 – Growth Strategies
24.3.1 Market Trend Based Strategies
24.3.2 Competitor Strategies
25 MASH Treatment Market, Conclusions And Recommendations
25.1 Conclusions
25.2 Recommendations
25.2.1 Product
25.2.2 Place
25.2.3 Price
25.2.4 Promotion
25.2.5 People
26 Appendix
26.1 Geographies Covered
26.2 Market Data Sources
26.3 Research Methodology
26.4 Currencies
26.5 The Business Research Company
26.6 Copyright and Disclaimer

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us